亚星化学(600319) - 2018 Q3 - 季度财报

Financial Performance - Operating revenue for the first nine months increased by 9.33% to CNY 1,567,788,849.28 compared to the same period last year[6]. - Net profit attributable to shareholders increased by 32.98% to CNY 10,496,206.25 compared to the same period last year[6]. - The net cash flow from operating activities surged by 259.00% to ¥43,326,781.13 from ¥12,078,193.29 in the same period last year[12]. - Total operating revenue for Q3 2018 reached ¥506,272,330.21, an increase of 3.5% compared to ¥488,426,303.14 in Q3 2017[27]. - Year-to-date operating revenue reached 1,567,788,849.28 RMB, up 9.3% from 1,434,045,963.84 RMB in the same period last year[31]. - The net profit for Q3 2018 was a loss of ¥5,874,881.13, compared to a profit of ¥448,477.15 in Q3 2017, indicating a significant decline[29]. - Total comprehensive income for Q3 2018 was -5,566,654.14 RMB, reflecting a decline from -88,861.71 RMB in Q3 2017[32]. - The company’s gross profit margin for the first nine months of 2018 was approximately 8.1%, compared to 10.6% in the same period last year[31]. Assets and Liabilities - Total assets decreased by 9.89% to CNY 1,370,441,555.96 compared to the end of the previous year[6]. - The total assets decreased from ¥1,513,516,222.52 at the beginning of the year to ¥1,341,865,728.80 by the end of Q3 2018, a reduction of approximately 11.3%[24]. - The total liabilities decreased from ¥1,480,358,994.12 at the beginning of the year to ¥1,300,151,737.28, a reduction of approximately 12.2%[24]. - Current liabilities decreased from ¥1,431,819,405.99 at the beginning of the year to ¥1,255,605,245.14, a decline of about 12.3%[24]. - The company's cash and cash equivalents dropped significantly from ¥209,666,221.86 at the beginning of the year to ¥55,948,817.68, a decrease of approximately 73.3%[24]. - Cash and cash equivalents decreased by 72.00% to CNY 59,493,179.23 compared to the beginning of the year[11]. - The total liabilities decreased from ¥1,488,205,029.57 to ¥1,328,153,715.30[20]. Cash Flow - Net cash flow from operating activities increased by 258.72% to CNY 43,326,781.13 compared to the same period last year[6]. - The net cash flow from investing activities improved significantly, reaching ¥21,629,567.02, a change of -1311.00% from -¥1,785,368.52 in the previous year[12]. - Cash flow from financing activities showed a net outflow of -127,724,887.78 RMB in the first nine months of 2018, compared to -102,498,085.87 RMB in the same period last year[34]. - Cash flow from investing activities showed a net outflow of 331,905.00 and 2,314,642.52 in the respective periods[37]. - Cash inflow from financing activities totaled 558,329,246.62 and 944,087,382.17, indicating a significant capital raise[37]. - The net cash flow from financing activities was -127,724,887.78 and -102,498,085.87, reflecting increased debt repayment[37]. - The company experienced a negative impact of -595,211.24 and -1,755,104.56 from foreign exchange fluctuations on cash and cash equivalents[37]. Shareholder Information - The total number of shareholders reached 19,742[8]. - Financial expenses increased significantly to 22,585,646.08 RMB in Q3 2018, compared to 8,319,821.48 RMB in Q3 2017, primarily due to higher interest expenses[31]. - The company paid 30,564,870.36 and 36,956,064.85 in dividends and interest payments, reflecting ongoing shareholder returns[37]. Inventory and Receivables - The company's inventory value decreased, with the difference between the current value and cost reducing compared to the same period last year[12]. - The accounts receivable increased to ¥212,299,351.15 from ¥183,540,971.96 at the beginning of the year[19]. - The company’s inventory increased from ¥169,404,140.03 at the beginning of the year to ¥178,733,421.53, an increase of about 5.8%[24]. Research and Development - Research and development expenses for Q3 2018 were ¥862,933.95, compared to ¥635,781.36 in Q3 2017, reflecting an increase of 35.7%[27]. - Research and development expenses for Q3 2018 were 862,933.95 RMB, up 35.7% from 635,781.36 RMB in Q3 2017[31].